Why Curamed
We aim to cure cancer. Our team is urgently working to create an arsenal of therapeutics that expands the reach and impact of antibodies used to treat cancer.
We chose the name Curamed because our next-generation therapies embody the precision and power of a crossbow. With unparalleled accuracy and potency, our T-Bolt molecules strike tumor cells like a crossbow shoots bolts at its target.
Join us on our bold quest to broaden the benefits of immunotherapy and improve the lives of people living with cancer.
TM
What we do
Migraine in the Workplace and Creating a Safe Space
One billion people worldwide live with migraine; that’s about one in seven. At those odds, there’s a high probability that each of us works with someone who experiences migraine. And if you’re an employer, this could mean that migraine in the workplace could have a significant impact on your workforce.Migraine is a debilitating neurological disease that causes intense pain in the head, as well as other sensory and/or motor dysfunction. Migraine attacks usually include symptoms like nausea...An Accord for a Healthier World
Where people live shouldn’t impact the quality of their healthcare and income shouldn’t determine health outcomes. -->Change the Odds: Uniting to Improve Cancer Outcomes
At Curamed we believe that everyone should have the same opportunity to access the latest advances in cancer care, regardless of their background or where they live. That’s why we’re proud to partner with the American Cancer Society on “Change the Odds: Uniting to Improve Cancer Outcomes,” a three-year initiative to bridge the gap in cancer care disparities. -->Who we are
A team of international, collaborative and experienced inventors, drug developers and company builders. We value scientific excellence, passion, integrity, innovation, transparency, respect and accountability. We embrace problems deemed impossible to solve.
Briggs Morrison,
M.D.
Chief Executive Officer, President
Benjamin Lee,
M.D., Ph.D.
Senior Vice President, Head of Translational Medicine
Dmitri
Wiederschain, Ph.D.
Chief Scientific Officer
Amanda Mak,
Ph.D.
Vice President, Head of Antibody Discovery, Protein Engineering, Process Development
Alexander Nolte,
C.P.A.
Senior Vice President, Head of Finance
Geraldine Paulus, Ph.D.
Co-founder, Vice President, Head of Corporate Development and Operations
Tao Wang,
M.S.
Vice President, Head of Product Discovery, Boston Site Head
Jeanette
Kohlbrenner, M.B.A.
Consulting Head of Human Resources
.png){kind=small}
_edited_edited.png)
_edited_edited.jpg)
_edited.jpg)
Join us
Working at Curamed
Hit your next career target at Curamed!
-
Principal Scientist, In vivo/In vitro
Pharmacology Lead – View full job description
Our people are the key to everything we accomplish. We offer outstanding programs to support your career and personal life.
-
Senior Manager/Associate Director,
Corporate Operations and Program Management – View full job description
-
Associate Director/Translational Medicine – View full job description
-
Senior Research Associate/Associate Scientist in Protein Analytics – View full job description
News & Media
Keep up to date with everything happening at Curamed.
March 5, 2024
Curamed Pharmaceuticals Selects First Development Candidate from its Portfolio of Next-Generation T-cell Engagers Directed at Intracellular Cancer Targets
October 11, 2023
Curamed Pharmaceuticals Announces Formation of its Scientific Advisory Board
July 11, 2023
Curamed Pharmaceuticals Launches with $80 Million in Series A Financing to Advance
a Novel Class of Antibody Therapies That Mimic T-Cell Receptors to Treat Cancer
